本页面由Tiger Trade Technology Pte. Ltd.提供服务

Faeth Therapeutics

33.22
+1.223.80%
成交量:5.78万
成交额:186.57万
市值:8.56亿
市盈率:-0.23
高:33.39
开:32.80
低:30.30
收:32.00
52周最高:37.90
52周最低:7.45
股本:2,577.88万
流通股本:81.17万
量比:0.57
换手率:7.12%
股息:- -
股息率:- -
每股收益(TTM):-141.6499
每股收益(LYR):-16.7239
净资产收益率:-195.26%
总资产收益率:-20.79%
市净率:4.95
市盈率(LYR):-1.99

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

重要事件披露

Form 8-K - Current report
2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/24

重要事件披露

Form 8-K - Current report
2026/06/23

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/23

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/19

重要事件披露

Form 8-K - Current report
2026/06/15

重要事件披露

Form 8-K - Current report
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/03

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/02

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/21

重要事件披露

Form 8-K - Current report
2026/05/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors